Literature DB >> 6489687

[Hepatitis secondary to a gold salt overdose].

A Jaeger, A Porte, P Sauder, M E Stoeckel, J M Mantz.   

Abstract

The authors report the case of a 51-year-old woman who developed cholestatic and cytolytic hepatitis after an overdose of sodium aurothiopropanol sulfonate 1.1 g, namely 300 mg gold metal. Liver biopsy demonstrated cholestasis, centrolobular steatosis and portal fibrosis. Electron microscopy showed abundant lipo-pigments in the hepatic and cellular cells, as well as myelinic bodies. Gold analysis by atomic absorption spectroscopy showed a level of 22.76 micrograms per ml in the plasma and a level of 2.16 micrograms per g in the liver. Chelating agents increased the urinary gold excretion, but were without effect on the course of hepatitis. Dimercaptopropanol seemed to favor the occurrence of other gold salt side-effects and penicillamine increased the hepatic cytolysis. The patient recovered without sequelae.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6489687

Source DB:  PubMed          Journal:  Gastroenterol Clin Biol        ISSN: 0399-8320


  3 in total

Review 1.  Drug-induced "allergic hepatitis".

Authors:  P Podevin; M Biour
Journal:  Clin Rev Allergy Immunol       Date:  1995       Impact factor: 8.667

2.  Cholestasis and pneumonitis induced by gold therapy.

Authors:  J M Farre; T Perez; P Hautefeuille; F Tonnel; J F Colombel; B Duquesnoy; B Delcambre
Journal:  Clin Rheumatol       Date:  1989-12       Impact factor: 2.980

Review 3.  Drug-induced cholestasis.

Authors:  H J Zimmerman; J H Lewis
Journal:  Med Toxicol       Date:  1987 Mar-Apr
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.